Drug Safety Communication - FDA Warns About Risk of Severe Itching After Discontinuation of Long-Term Use of Allergy Medicines Cetirizine or Levocetirizine
Audience: Consumer, Patient, Health Care Professional, Pharmacy, Dermatology May 23, 2025 -- The FDA is warning that patients stopping the oral allergy medicines cetirizine (Zyrtec) or levocetirizine (Xyzal) after long-term use may experience rare...
Audience: Consumer, Patient, Health Care Professional, Pharmacy, Dermatology May 23, 2025 -- The FDA is warning that patients stopping the oral allergy medicines cetirizine (Zyrtec) or levocetirizine (Xyzal) after long-term use may experience rare...
